Skip to main content
JIANGSU SIHUAN BIOENGINEERING CO.,LTD logo

JIANGSU SIHUAN BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000518 ISIN · CNE0000001P8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,779 across all filing types
Latest filing 2026-04-17 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 000518

About JIANGSU SIHUAN BIOENGINEERING CO.,LTD

https://www.000518shsw.com

Jiangsu Sihuan Bioengineering Co., Ltd. specializes in the research, development, and production of biopharmaceutical products and traditional Chinese medicines. The company’s core product line features genetic engineering drugs, including recombinant human interleukin-2 (rhIL-2) and recombinant human granulocyte colony-stimulating factor (rhG-CSF). Its manufacturing capabilities encompass various dosage forms such as injections, capsules, and tablets, adhering to rigorous quality standards. In addition to its pharmaceutical core, the company manages ecological restoration and landscape engineering initiatives. The organization focuses on leveraging biotechnology to provide therapeutic solutions for oncology and immune-related conditions, maintaining a commitment to scientific innovation and clinical efficacy.

Recent filings

Filing Released Lang Actions
江苏四环生物股份有限公司非经营性资金占用及其他关联资金往来情况汇总表的专项审核报告
Audit Report / Information Classification · 92% confidence The document is a standalone “专项审核报告” prepared and signed by an external registered public accounting firm (China Audit Asia Pacific Certified Public Accountants LLP) relating to the company’s 2025 summary table of non-operating and related-party fund transactions. It contains the auditor’s scope, responsibilities under Chinese CPA auditing standards, audit procedures, and an opinion on the specific summary table (附表). This matches the definition of an Audit Report / Information (AR), rather than a full annual report or mere notice announcing a report. Consequently, the correct classification is AR. FY 2025
2026-04-17 Chinese
2025年年度报告
Annual Report Classification · 100% confidence The document is titled "江苏四环生物股份有限公司2025 年年度报告全文" which translates to "Jiangsu Sihuan Bioengineering Co., Ltd. 2025 Annual Report Full Text." It contains detailed sections typical of an annual report, including company overview, financial data, management discussion and analysis, governance, and audited financial statements. The document length is 15,000 characters, indicating a full report rather than a brief announcement. It includes signatures from company officers and auditors, detailed financial metrics, and comprehensive business and industry analysis. These characteristics align with the definition of an Annual Report (10-K). FY 2025
2026-04-17 Chinese
江苏四环生物股份有限公司关于公司股票可能被终止上市的第五次风险提示公告
Delisting Announcement Classification · 95% confidence The document is a risk warning announcement regarding the potential delisting of the company's stock due to financial conditions and regulatory compliance issues. It references specific stock exchange listing rules and past announcements about delisting risk warnings. The document does not contain actual financial statements or detailed financial data but rather serves as a formal notice to investors about the risk of stock termination from the exchange. The document length is relatively short (2511 characters) and is clearly an announcement rather than a full report. Therefore, it fits the category of a Delisting Announcement (DLST).
2026-04-03 Chinese
江苏四环生物股份有限公司关于2025年年度报告编制及审计进展情况的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Jiangsu Sihuan Bio Co., Ltd. regarding the preparation and audit progress of its 2025 annual report. It mentions that the audited financial data is not yet finalized and that the audit is ongoing. The document is relatively short (1158 characters) and serves to update shareholders on the status of the annual report preparation and audit progress, rather than presenting the full annual report itself. It also references regulatory requirements for disclosure related to delisting risk warnings and audit progress updates. Since this is a progress announcement about the annual report and audit, not the annual report itself, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance update rather than the full Annual Report (10-K) or Audit Report (AR).
2026-04-03 Chinese
江苏四环生物股份有限公司关于2025年年度报告编制及审计进展情况的公告
Report Publication Announcement Classification · 95% confidence The document is an announcement from Jiangsu Sihuan Bio Co., Ltd. regarding the progress of the preparation and audit of its 2025 annual report. It mentions that the audit is ongoing and that the final financial data will be subject to the audit report. The document is relatively short (1159 characters) and primarily provides an update on the status of the annual report and audit, rather than containing the full annual report or detailed financial statements. It also references regulatory requirements for disclosure related to delisting risk warnings and audit progress updates. Since this is an announcement about the report preparation and audit progress, not the report itself, it fits the category of Report Publication Announcement (RPA) rather than the Annual Report (10-K) or Audit Report (AR).
2026-03-20 Chinese
江苏四环生物股份有限公司关于公司股票可能被终止上市的第四次风险提示公告
Delisting Announcement Classification · 95% confidence The document is a risk warning announcement regarding the potential delisting of the company's stock. It references specific regulatory rules from the Shenzhen Stock Exchange about conditions that could lead to termination of listing, including financial criteria and disclosure obligations. The document repeatedly mentions previous risk warning announcements and emphasizes ongoing disclosure obligations. It does not contain actual financial statements or detailed financial data but serves as a formal risk notification to investors about the possibility of stock delisting. The document length is relatively short (2449 characters), and it is clearly an announcement rather than a full report. Therefore, it fits the category of a Delisting Announcement (DLST).
2026-03-20 Chinese

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.